全球生物製藥生物分離系統市場

Biopharmaceutical Bioseparation Systems

出版日期: 2025年02月06日 | 出版商:

Global Industry Analysts, Inc. | 英文 360 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球生物製藥生物分離系統市場規模將達到 326 億美元

2024 年全球生物製藥生物分離系統市場規模估計為 175 億美元，預計 2030 年將達到 326 億美元，2024 年至 2030 年的複合年成長率為 10.9%。層析法技術是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 10.2%，達到 158 億美元。預計分析期間其他技術部門的複合年成長率為 11.5%。

美國市場規模估計為 73 億美元，中國市場預估年複合成長率為 13.3%

預計 2024 年美國生物製藥生物分離系統市場規模將達 73 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 39 億美元，2024-2030 年分析期間的複合年成長率為 13.3%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 9.0% 和 9.3%。在歐洲，德國的複合年成長率預計為 9.8%。

全球生物製藥生物分離系統市場 - 主要趨勢和促進因素摘要

生物製藥生物分離系統是生物製藥生產和精製的重要組成部分，包括治療性蛋白質、單株抗體、疫苗等。這些系統採用多種技術，包括層析法、過濾和離心法，從複雜混合物中分離和精製生物分子。由於生物製藥在治療慢性和罕見疾病方面的有效性，對生物製藥的需求日益增加，從而推動了對高效、可靠的生物分離系統的需求。這些系統對於確保生物製藥的純度、效力和安全性至關重要，因為生物製藥必須遵守嚴格的監管要求。生物分離技術的進步使得生物製藥製造過程更有效率、擴充性。

由於生物製藥行業的擴張和先進生物分離技術的不斷採用，生物製藥生物分離市場正在經歷顯著的成長。慢性病的流行、人口老化以及個人化醫療需求的不斷成長正在刺激生物製藥的生產。此外，基因和細胞療法等新治療方法的發展為生物分離技術帶來了新的挑戰和機會。材料和方法的創新，例如使用一次性系統和連續處理，使生物分離過程更有效率、更具成本效益。這些進步使得生物製藥的生產能夠更大規模、更高品質地進行。

生物製藥生物分離系統市場的成長受到多種因素的推動。首先，由於慢性病的流行和人口老化，對生物製藥的需求不斷增加，推動了對高效生物分離系統的需求。其次，一次性系統和連續處理等生物分離技術的進步，使得生物製藥生產更具擴充性和成本效益。第三，基因和細胞療法等新治療方法的發展為生物分離帶來了新的挑戰和機遇，推動了該領域的創新。最後，生物製藥的嚴格監管要求使得必須使用先進的生物分離系統來確保產品品質和安全。總的來說，這些因素促進了生物製藥生物分離系統市場的強勁成長。

部分

技術（層析法、其他技術）

受訪企業範例（共61家）

3M Company
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Alfa Laval AB
GEA Group AG
AMS Biotechnology（Europe）Ltd.（amsbio）
Biotage AB
AnteoTech
BIA Separations doo
Heinkel Drying and Separation Group
3B Pharmaceuticals GmbH
Critical Process Filtration, Inc.
Flottweg SE
Ellutia
Global Life Sciences Solutions USA LLC（Cytiva）

The global market for Biopharmaceutical Bioseparation Systems estimated at US$17.5 Billion in the year 2024, is expected to reach US$32.6 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Other Technologies segment is estimated at 11.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.3 Billion While China is Forecast to Grow at 13.3% CAGR

The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$7.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Biopharmaceutical Bioseparation Systems Market - Key Trends & Drivers Summarized

Biopharmaceutical bioseparation systems are critical components in the production and purification of biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, and vaccines. These systems employ various techniques such as chromatography, filtration, and centrifugation to separate and purify biological molecules from complex mixtures. The demand for biopharmaceuticals is increasing due to their effectiveness in treating chronic and rare diseases, driving the need for efficient and reliable bioseparation systems. These systems are essential for ensuring the purity, potency, and safety of biopharmaceutical products, which are subject to stringent regulatory requirements. Advances in bioseparation technologies are enhancing the efficiency and scalability of biopharmaceutical manufacturing processes.

The biopharmaceutical bioseparation market is experiencing significant growth due to the expanding biopharmaceutical industry and the increasing adoption of advanced bioseparation techniques. The rise in the prevalence of chronic diseases, the aging population, and the growing demand for personalized medicine are fueling the production of biopharmaceuticals. Additionally, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation technologies. Innovations in materials and methods, such as the use of single-use systems and continuous processing, are improving the efficiency and cost-effectiveness of bioseparation processes. These advancements are enabling the production of high-quality biopharmaceuticals at larger scales.

The growth in the biopharmaceutical bioseparation systems market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals, driven by the prevalence of chronic diseases and the aging population, is boosting the need for efficient bioseparation systems. Secondly, advancements in bioseparation technologies, including single-use systems and continuous processing, are enhancing the scalability and cost-effectiveness of biopharmaceutical manufacturing. Thirdly, the development of novel therapies such as gene and cell therapies is creating new challenges and opportunities for bioseparation, driving innovation in this field. Lastly, stringent regulatory requirements for biopharmaceutical products are necessitating the use of advanced bioseparation systems to ensure product quality and safety. These factors collectively contribute to the robust growth of the biopharmaceutical bioseparation systems market.

SCOPE OF STUDY:

The report analyzes the Biopharmaceutical Bioseparation Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Chromatography, Other Technologies)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

3M Company
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Alfa Laval AB
GEA Group AG
AMS Biotechnology (Europe) Ltd. (amsbio)
Biotage AB
AnteoTech
BIA Separations d.o.o.
Heinkel Drying and Separation Group
3B Pharmaceuticals GmbH
Critical Process Filtration, Inc.
Flottweg SE
Ellutia
Global Life Sciences Solutions USA LLC (Cytiva)

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Impact of COVID-19 on Biopharmaceutical Bioseparation Market
- Scope of Affinity Chromatography in Aiding the Vaccine Purification methodology
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Biopharmaceutical Bioseparation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
- A Prelude to Biopharmaceutical Bioseparation Systems
- A Peek into Biopharmaceutical Manufacturing
- Downstream Processing of Biosynthetic Products - An Overview
- Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
- US Remains Market Leader; Developing Countries to Drive Market Growth
- Chromatography Leads the Pack
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
- Top 10 Biopharmaceutical Companies: 2023
- Biological License Application (BLA) Approvals - 2023
- Targeted Therapies Gain Momentum, Cancer Immunotherapies on the Rise
- Process Intensification Aids in Greater Productivity
- Evolution of Chromatography Applications for the Biopharmaceutical Sector
- Chromatography in Cell & Gene Therapies
- Chromatography Methods Fraught with Issues
- Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies
- Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
- Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
- Specific Guidelines for Biosimilars in Various Countries with Year of Publication
- Biosimilars Regulatory Agencies in Select Regional Markets
- Biosimilar Approvals in the US (2023)
- Biosimilar Approvals in Europe (2023)
- High Demand for Monoclonal Antibodies Generates Significant Opportunities for Bioseparation Systems
- Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
- Chromatography - The Gold Standard Separation Technology
- Global Chromatography Market (2023): Percentage Share Breakdown of Value Sales by Chromatography Techniques for Gas Chromatography, Liquid Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography, and Others
- Increasing Demand for Gas Chromatography in Biopharma Separation
- Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
- A Comparison of Protein and Synthetic Ligands
- Pre-packed Disposable Columns in Chromatography Gain Attention
- SMBC - An Old Approach Gaining Significant Attention
- Major Advantages and Disadvantages of SMBC
- Twin-Column SMB - An Emerging Alternative to Protein A Columns
- Growing Focus on Alternatives to Protein A Chromatography
- Chiral Chromatography Increases in Popularity
- Chromatography Efficiency and Selectivity
- Mixed-Mode Chromatography
- Multimode Chromatography
- Mixed-Mode and Multimode Media Offer Cost Savings
- Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
- Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
- His-tagged purification of protein & Immobilized Metal Affinity Chromatography (IMAC)
- Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
- Downstream Production of Biopharmaceuticals: Filtration Challenges
- Evolving Membrane Functions in Filtration for the Production of mAbs
- Filtration Technology: The Future
- Membrane Adsorbers Gain Ground in Biopharmaceutical Downstream Purification
- Prospering Vaccine Market Drives Use of Ultrafiltration Techniques
- Membrane & Bioseparation
- Need for Highly Efficient Membranes Rises
- Downstream Response of Industry to Upstream Scale-Up
- Hand-powered Centrifuge setup can Diagnose Covid-19 for just a dollar a test
- Cell Disruption & Methods Gain Popularity
- Advent of Innovative Technologies Streamline and Enhance Production of Biopharmaceutical Systems
- Affinity Technologies Improve Productivity
- Nanofiber Chromatography Technology Advantageous
- Convective Media Set to Gain Growing Use
- Nanotechnology Set to Add Interesting Dimension to Biological Separation
- Rise of Magnetic Nanoparticles
- Magnetic Biological Separation: Key Steps
- Why Carbon Nanotubes are Gaining Attention
- Application of Nanoporous & Nanofiber Membranes
- Key Challenges & the Road Ahead
- Continuous Bioprocessing Holds Potential to Positively Impact Biomanufacturing
- Perfusion Gains Attention
- Use of Continuous Purification on the Rise in Viral Processes
- Introduction of Integrated Continuous Bioprocessing System Improves Productivity and Minimizes Raw Material Wastage
- Use of Continuous Processing Technique for Manufacturing Life-Saving Medicines Gains Momentum
- Demand for Sustainable Nanofiber Chromatography Mechanism Witnesses an Upward Momentum
- Use of Precipitation Technique for Purifying Therapeutic Proteins Exhibits a Surge
- Continuous Bioseparation Gains Momentum
- Single-Use Systems Play a Key Role
- Minimizing Centrifugation Steps
- Single-Use Disposable Technologies Gain Attention
- Innovative Approaches to Overcome Perennial & Existing Challenges with Process Chromatography
- Increase in Healthcare Spending Stirs Demand for Biopharmaceutical Bioseperation Systems
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
- Growing Preference for Personalized Medicine to Drive Market Growth
- Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Biopharmaceutical Bioseparation Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Market Facts & Figures
- Market Analytics
- TABLE 11: USA Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: USA 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: Canada 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
JAPAN
- TABLE 17: Japan Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: Japan 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
CHINA
- TABLE 20: China Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: China Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: China 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
EUROPE
- Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
FRANCE
- TABLE 29: France Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: France Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: France 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
GERMANY
- TABLE 32: Germany Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: Germany 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Italy 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
UNITED KINGDOM
- TABLE 38: UK Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: UK 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
SPAIN
- TABLE 41: Spain Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: Spain Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: Spain 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
RUSSIA
- TABLE 44: Russia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: Russia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Russia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Rest of Europe 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
ASIA-PACIFIC
- Biopharmaceutical Bioseparation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
AUSTRALIA
- TABLE 56: Australia Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Australia Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Australia 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
INDIA
- TABLE 59: India Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: India Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: India 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
SOUTH KOREA
- TABLE 62: South Korea Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: South Korea Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: South Korea 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Rest of Asia-Pacific Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
LATIN AMERICA
- TABLE 68: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 69: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
ARGENTINA
- TABLE 74: Argentina Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: Argentina Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: Argentina 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
BRAZIL
- TABLE 77: Brazil Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Brazil Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Brazil 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
MEXICO
- TABLE 80: Mexico Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Mexico Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Mexico 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Rest of Latin America Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Rest of Latin America 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
MIDDLE EAST
- TABLE 86: Middle East Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Middle East Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: Middle East 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030
AFRICA
- TABLE 89: Africa Recent Past, Current & Future Analysis for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Africa Historic Review for Biopharmaceutical Bioseparation Systems by Technology - Chromatography and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: Africa 15-Year Perspective for Biopharmaceutical Bioseparation Systems by Technology - Percentage Breakdown of Value Revenues for Chromatography and Other Technologies for the Years 2015, 2025 & 2030